Testing effectiveness (Phase 2)Looking for participantsNCT05135975
What this trial is testing
Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
Who this might be right for
NeuroblastomaSarcoma
Nationwide Children's Hospital 86